Table 1 Comparison of baseline clinical characteristics of the two groups
Variables | Overall (n = 49) | PFA (n = 25) | RFCA (n = 24) | P value |
|---|---|---|---|---|
Age, mean (SD), years | 50.29 (12.16) | 50.52 (12.82) | 50.04 (11.71) | 0.464 |
Sex, n (%) | ||||
 Male | 23 (47) | 11 (44) | 12 (50) | 0.674 |
 Female | 26 (53) | 14 (56) | 12 (50) | |
 Weight, mean (SD), kg | 65.02 (12.11) | 65 (11.28) | 65.04 (13.16) | 0.292 |
 Serum potassium, mean (SD), mmol/L | 4.03 (0.54) | 4.04 (0.60) | 4.01 (0.49) | 0.664 |
 Duration of PSVT, mean (SD), d | 1483.04 (1765.39) | 1406.96 (1909.37) | 1575.71 (1637.60) | 0.204 |
PSVT type, n (%) | ||||
 DAVNP | 31 (63) | 16 (54) | 15 (62) | 0.866 |
 Right AP | 5 (10) | 3 (12) | 2 (8) | |
 Left AP | 13 (26) | 6 (24) | 7 (29) | |
Cardiac ultrasound indicators | ||||
 LAD, mean (SD), mm | 32.90 (4.78) | 32.56 (4.98) | 33.25 (4.64) | 0.559 |
 LVEF, mean (SD), mm | 67.35 (8.34) | 66.84 (10.48) | 67.88 (5.47) | 0.139 |
Comorbidities, n (%) | ||||
 ACD | 4 (8) | 2 (8) | 2 (8) | 0.680 |
 Hypertension | 6 (12) | 4 (16) | 2 (8) | 0.354 |
 DM | 4 (8) | 2 (8) | 2 (8) | 0.680 |